Skip to main content

Table 4 Clinical, laboratory variables and outcomes in each group of neonates admitted within 3 days of life

From: Early-onset neonatal sepsis and antibiotic use in Indonesia: a descriptive, cross-sectional study

Clinical and laboratory variables Received antibiotic within 3d of life (n = 1,039)
EOS Non-EOS
(n = 797)
Culture proven
(n = 83)
Culture negative
(n = 112)
Absence of culture facility
(n = 47)
Total
(n = 242)
Temperature instability 68
(81.9%)
81 (72.3%) 40 (85.1%) 189 (78.1%) 219 (27.5%)
Increased oxygen requirement or ventilatory support 65 (78.3%) 88 (78.6%) 44 (93.6%) 197 (81.4%) 355 (44.5%)
Glucose intolerance 64 (77.1%) 56 (50.0%) 11 (23.4%) 131 (54.1%) 121 (15.2%)
Lethargy 62 (74.7%) 63 (56.3%) 30 (63.8%) 155 (64.0%) 133 (16.7%)
Ileus/feeding intolerance or abdominal distension 52 (62.7%) 48 (42.9%) 21 (44.7%) 121 (50.0%) 81 (10.2%)
Increase in apnoeic or bradycardic episodes or tachycardia 24
(28.9%)
38 (33.9%) 13 (27.7%) 75 (31.0%) 56 (7.0%)
Hypotension or prolonged capillary refill 5 (6.0%) 15 (13.4%) 12 (25.5%) 32 (13.2%) 31 (3.9%)
Base deficit > 10 mmol/L 5 (6.0%) 34 (30.4%) 0 (0.0%) 39 (16.1%) 62 (7.8%)
Outcomes
 14-d mortality 12 (14.5%) 27 (24.1%) 3 (6.4%) 42 (17.4%) 78 (9.8%)
 28-d mortality 21 (25.3%) 28 (25.0%) 3 (6.4%) 52 (21.5%) 81 (10.2%)